[
  {
    "date": "2023-12-30",
    "symbol": "MRNS",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-36576",
    "entityregistrantname": "Marinus Pharmaceuticals,Â Inc.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "20-0198082",
    "entityaddressaddressline1": "5 Radnor Corporate Center, Suite 500",
    "entityaddressaddressline2": "100 Matsonford Road",
    "entityaddresscityortown": "Radnor",
    "entityaddressstateorprovince": "PA",
    "entityaddresspostalzipcode": 19087,
    "cityareacode": 484,
    "localphonenumber": "801-4670",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "tradingsymbol": "MRNS",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Philadelphia, Pennsylvania",
    "entitycentralindexkey": 1267813,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "cashandcashequivalentsatcarryingvalue": 120572000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 29716000,
    "accountsreceivablenetcurrent": 3799000,
    "inventorynet": 2413000,
    "prepaidexpenseandotherassetscurrent": 8746000,
    "assetscurrent": 165246000,
    "propertyplantandequipmentnet": 3843000,
    "otherassetsnoncurrent": 1819000,
    "assets": 170908000,
    "accountspayablecurrent": 4003000,
    "notespayablecurrent": 11551000,
    "revenueinterestfinancingpayablecurrent": 2211000,
    "accruedliabilitiescurrent": 22859000,
    "liabilitiescurrent": 40624000,
    "longtermnotespayable": 61423000,
    "revenueinterestfinancingpayablenetofdeferredofferingcostsnoncurrent": 33766000,
    "contractwithcustomercontractliabilitynetofcontractasset": 17545000,
    "otheraccruedliabilitiesnoncurrent": 785000,
    "liabilities": 154143000,
    "commonstockvalue": 55000,
    "additionalpaidincapital": 588656000,
    "accumulatedothercomprehensiveincomelossnetoftax": -20000,
    "retainedearningsaccumulateddeficit": -571926000,
    "stockholdersequity": 16765000,
    "liabilitiesandstockholdersequity": 170908000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 25000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 54585428,
    "commonstocksharesoutstanding": 54578121,
    "treasurystockcommonshares": 7307,
    "revenuefromcontractwithcustomerexcludingassessedtax": 19561000,
    "revenuenotfromcontractwithcustomer": 11374000,
    "revenues": 30989000,
    "researchanddevelopmentexpense": 99388000,
    "sellinggeneralandadministrativeexpense": 61152000,
    "costofgoodsandservicessold": 1909000,
    "costsandexpenses": 162474000,
    "operatingincomeloss": -131485000,
    "investmentincomeinterest": 8113000,
    "interestexpense": 16895000,
    "gainlossonsaleofpriorityreviewvouchernet": -4000000,
    "othernonoperatingincomeexpense": 1324000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -142943000,
    "incometaxexpensebenefit": -1538000,
    "netincomelossavailabletocommonstockholdersbasic": -141405000,
    "earningspersharebasic": -2.63,
    "earningspersharediluted": -2.63,
    "weightedaveragenumberofsharesoutstandingbasic": 53746518,
    "weightedaveragenumberofdilutedsharesoutstanding": 53746518,
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletoparent": -20000,
    "comprehensiveincomenetoftax": -141425000,
    "sharesoutstanding": 54578121,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 15563000,
    "stockissuedduringperiodvaluestockoptionsexercised": 804000,
    "stockissuedduringperiodsharesstockoptionsexercised": 126735,
    "stockissuedduringperiodsharessharebasedcompensation": 258819,
    "stockissuedduringperiodvalueconversionofconvertiblesecuritiesnetofadjustments": -4043000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -4300,
    "stockissuedduringperiodvalueequitydistributionagreement": 4000,
    "stockissuedduringperiodsharesequitydistributionagreement": 3689800,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -20000,
    "netincomeloss": -141405000,
    "shareprice": 7.17,
    "stockissuancecosts": 529000,
    "profitloss": -141405000,
    "depreciation": 551000,
    "amortizationoffinancingcosts": 2248000,
    "accretionofrevenueinterestfinancingdebt": 4806000,
    "investmentincomeamortizationofdiscount": 1241000,
    "sharebasedcompensation": 15563000,
    "increasedecreaseamortizationofnetcontractassetliability": 1353000,
    "noncashoperatingleaseexpenseoperatingactivities": 187000,
    "interestexpenseincomeonleaseliabilities": 413000,
    "fixedassetswrittenoff": 61000,
    "increasedecreaseincontractwithcustomerasset": -2613000,
    "increasedecreaseinprepaidexpenseandotherassetsnoncurrentassetsinventoryandaccountsreceivable": 2552000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 2108000,
    "netcashprovidedbyusedinoperatingactivities": -118001000,
    "proceedsfromsaleofpropertyplantandequipment": 9000,
    "proceedsfromsalematurityandcollectionsofinvestments": 23500000,
    "paymentstoacquireinvestments": 51995000,
    "paymentstoacquiremachineryandequipment": 119000,
    "netcashprovidedbyusedininvestingactivities": -28605000,
    "proceedsfromstockoptionsexercised": 804000,
    "proceedsfromequityofferingsnet": 25823000,
    "netcashprovidedbyusedinfinancingactivities": 26627000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -119979000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 120572000,
    "increaseinrightofuseassetandliability": 66000,
    "interestpaidnet": 8697000,
    "incometaxespaidnet": 903000,
    "cashcashequivalentsandshortterminvestments": 150300000,
    "concentrationriskpercentagecumulativeminimum": 0.99,
    "numberofcustomers": 3,
    "tradereceivablepaymentterm": "P30D",
    "costofinventoryincludedinresearchanddevelopmentexpensepriortofdaapproval": 2000000,
    "numberofoperatingsegments": 1,
    "accruedclinicaltrialexpensescurrent": 4700000,
    "prepaidclinicalexpenses": 5200000,
    "propertyplantandequipmentusefullife": "P5Y",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1271894,
    "cashandcashequivalentsfairvaluedisclosure": 1255000,
    "investmentsfairvaluedisclosure": 26835000,
    "assetsfairvaluedisclosure": 120572000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 26852000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 138000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 155000,
    "availableforsalesecuritiesdebtsecurities": 26835000,
    "propertyplantandequipmentgross": 4330000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1900000,
    "depreciationandamortization": 500000,
    "assetsheldforsalenotpartofdisposalgroup": 100000,
    "employeerelatedliabilitiescurrent": 7746000,
    "clinicaltrialsanddrugdevelopmentcurrent": 4701000,
    "accruedlicenseagreementpayment": 4000000,
    "accruedprofessionalfeescurrent": 1236000,
    "sellingandcommercialliabilitiescurrent": 3901000,
    "leaseliabilityshortterm": 774000,
    "otheraccruedliabilitiescurrent": 501000,
    "lesseeoperatingleasetermofcontract": "P78M",
    "lesseeoperatingleaserenewalterm": "P60M",
    "operatingleaseweightedaverageremainingleaseterm1": "P21M",
    "operatingleaserightofuseasset": 1000000,
    "operatingleaserightofuseassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent",
    "operatingleaseliability": 1400000,
    "operatingleasenumberofleasearrangement": 1,
    "leasecost": 600000,
    "shorttermleasecost": 100000,
    "lesseeoperatingleasediscountrate": 0.11,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 889000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 662000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1551000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 144000,
    "operatingleaseliabilitystatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesNoncurrent",
    "operatingleaseliabilitycurrent": 774000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent",
    "operatingleaseliabilitynoncurrent": 633000,
    "operatingleaseliabilitynoncurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesNoncurrent",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 577,
    "commonstockcapitalsharesreservedforfutureissuance": 907095,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1257019,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 566685,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 2500,
    "allocatedsharebasedcompensationexpense": 5806000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "stockissuedduringperiodsharesnewissues": 3700000,
    "proceedsfromissuanceorsaleofequity": 25800000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 267239,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 288715,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4620748,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.64,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.43,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.35,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 8.34,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 13.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 17854000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 9292000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0335,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 15600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 6400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 12690000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 262819,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 141573,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 6.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 8.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 6.61,
    "maximumsharesavailableforissuancevalueequitydistributionagreement": 75000000,
    "equitydistributionagreementcommissionpercentagemaximum": 0.03,
    "conversionofstocksharesconverted1": 4300,
    "conversionofstocksharesissued1": 860000,
    "contractualtermloanexitfees": 2003000,
    "interestexpensedebt": 8700000,
    "debtinstrumentcarryingamount": 75000000,
    "debtinstrumentminimumliquiditycovenant": 15000000,
    "debtinstrumentunamortizeddiscountpremiumanddebtissuancecostsnet": 4029000,
    "notespayable": 72974000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 11250000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 15000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 48750000,
    "longtermdebt": 75000000,
    "revenueinterestfinancingagreementissuancecosts": 2600000,
    "revenueinterestfinancingagreementestimatedeffectiveannualinterestrate": 0.18,
    "revenueinterestfinancingagreements": 35977000,
    "revenueinterestfinancingagreementnoncashinterestincomeexpense": 5950000,
    "revenueinterestfinancingagreementamortizationofdebtdiscount": 294000,
    "revenueinterestfinancingagreementpayments": -1144000,
    "amortizationoftransactionpricereductioninresearchanddevelopmentcosts": 1400000,
    "transactionprice": 21660000,
    "contractwithcustomerliability": 13700000,
    "contractwithcustomerassetnet": 2900000,
    "contractacquisitioncosts": 2000000,
    "contractacquisitionexpense": 1100000,
    "capitalizedcontractcostnet": 900000,
    "cumulativecollaborationrevenuerecognized": 21660000,
    "definedcontributionplanemployermatchingcontributionpercent": 0.03,
    "definedcontributionplanemployerdiscretionarycontributionamount": 1100000,
    "definedcontributionplanemployercontributionvestingperiod": "P4Y",
    "collaborativearrangementsexpirationperiodofobligationtopayroyalties": "P10Y",
    "agreedtopaycashunderlicenseagreement": 1500000,
    "agreedtoissuenumberofsharesofcommonstockunderlicenseagreement": 123255,
    "optiontoobtainsharesofcommonstockexercisablefollowingfilingofannualreportmaximumperiod": "P5D",
    "currentstateandlocaltaxexpensebenefit": -1538000,
    "currentincometaxexpensebenefit": -1538000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -142943000,
    "operatinglosscarryforwards": 292200000,
    "operatinglosscarryforwardssubjecttoexpiration": 81100000,
    "taxcreditcarryforwardamount": 39200000,
    "deferredtaxassetsoperatinglosscarryforwards": 72792000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1754000,
    "deferredtaxassetsamortization": 468000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 8741000,
    "deferredtaxassetstaxcreditcarryforwards": 39588000,
    "deferredtaxassetleaseliability": 345000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpenses": 37643000,
    "deferredtaxassetsroyaltyordeferredrevenue": 4298000,
    "deferredtaxassetscapitallosscarryforwards": 74000,
    "deferredtaxassetinterestcarryforward": 2152000,
    "deferredtaxassetsother": 152000,
    "deferredtaxassetsgross": 168007000,
    "deferredtaxliabilitiesrightofuseasset": 237000,
    "deferredtaxliabilitiespropertyplantandequipment": 458000,
    "deferredtaxliabilitiestaxdeferredincome": 209000,
    "deferredincometaxliabilities": 904000,
    "deferredtaxassetsliabilitiesbeforevaluationallowance": 167103000,
    "deferredtaxassetsvaluationallowance": 167103000,
    "valuationallowancedeferredtaxassetchangeinamount": 43700000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.004,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.041,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.063,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.025,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.306,
    "effectiveincometaxratereconciliationtaxcreditsother": 0.018,
    "effectiveincometaxratecontinuingoperations": 0.011
  }
]